Skip to content
Screener

Vertex Pharmaceuticals VRTX Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
Total revenue
$3.33B+12.5%$2.99B+7.8%$3.19B+9.5%$3.08B+11.0%$2.96B+12.1%
Total cost of revenue
$489.2M+20.0%$392.8M+8.2%$466M+10.1%$414.8M+5.7%$407.5M+9.6%
Gross profit
$2.84B+11.2%$2.59B+7.8%$2.72B+9.5%$2.66B+11.9%$2.56B+12.5%
Gross margin
85.3%-0.9pp86.8%0.0pp85.4%-0.1pp86.5%+0.7pp86.3%+0.3pp
Selling, general and administrative
$582.2M+37.1%$493.7M+24.5%$487M+29.0%$445.1M+19.7%$424.6M+14.1%
Total costs & expenses
$2.09B+15.1%$1.85B-13.6%$1.98B+5.2%$1.89B+14.2%$1.81B-70.6%
Operating income
$1.25B+8.3%$1.14B+80.6%$1.21B—$1.19B+6.3%$1.15B+133%
Operating margin
37.4%-1.4pp38.1%+15.4pp37.8%—38.6%-1.7pp38.8%+172pp
Income before income taxes
$1.39B+8.5%$1.25B+71.5%$1.33B+17.1%$1.3B+6.1%$1.28B+138%
Income tax expense
$292M+16.8%$221.5M+163%$139.9M-37.4%$215.9M+20.8%$250.1M+23.6%
Net income
$1.1B+6.5%$1.03B+59.6%$1.19B—$1.08B+3.6%$1.03B+129%
Net margin
33%-1.9pp34.5%+11.2pp37.3%—35.2%-2.5pp34.8%+171pp
Diluted earnings per share
$4.31+8.0%$4.02+61.4%$4.64—$4.20+4.7%$3.99+129%
EBIT
$1.25B+8.3%$1.14B+80.6%$1.21B+5.8%$1.19B+6.3%$1.15B+133%

FAQ

What is Vertex Pharmaceuticals's revenue?
Vertex Pharmaceuticals (VRTX) generated $12.6B in revenue over the trailing twelve months, up 10.2% year over year.
Is Vertex Pharmaceuticals profitable?
Vertex Pharmaceuticals reported $4.4B in net income over the trailing twelve months, a 35.0% net margin.
What are Vertex Pharmaceuticals's profit margins?
Gross margin is 86.0% and operating margin is 38.0%, with a 35.0% net margin.
What is Vertex Pharmaceuticals's earnings per share?
Vertex Pharmaceuticals's diluted EPS over the trailing twelve months is $17.17.
Where does Vertex Pharmaceuticals's income statement data come from?
Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.